Phylogica Limited

ASX:PYC ISIN:AU000000PYC7

Phylogica Limited (Phylogica) is an Australia-based company principally engaged in the discovery and development of therapeutics directed at proteins and their interactions. The Company is engaged in the discovery of peptide-based drugs to treat inflammatory diseases.  
 
        

查看其它語言版本

新聞

2010年12月20日澳洲股市:IMX Resources (ASX:IXR)首批鐵銅礦石船運貨物發往中國

🕔12/20/2010 1:30:00 PM 12699

2010年12月20日澳洲股市:IMX Resources (ASX:IXR)已向中國發運第一批鐵銅礦石貨物;澳洲藥品開發公司Phylogica Limited (ASX:PYC)已與輝瑞製藥(NYSE:PFE)簽訂合作與許可證協議;Copper Strike Limited (ASX:CSE)在昆士蘭西北部的Walford Creek項目已取得良好的銅/銀/鈷結果;South American Ferro Metals Limited (ASX:SFZ)在巴西生產的鐵礦石超出400,000噸。

閱讀全文
###

90,779 公司背景瀏覽

  • 本頁瀏覽人次: (過去7日: 29) (過去30日: 139) (自發布以來: 10037) 

公司詳細

    傳真
  • 08 9423 8899 
  • 主要部門
  • 醫療-製藥 
  • 支柱產業
  • 生物科技 
  • 主頁
  • www.phylogica.com/

更多新聞紀錄

  • 2025/03/28: Investor Webinar Presentation*
  • 2025/03/21: Application for quotation of securities - PYC*
  • 2025/03/21: Q1 Investor Webinar 28 March 2025*
  • 2025/03/18: Completion of Retail Entitlement Offer*
  • 2025/02/27: Change of Director's Interest Notice*
  • 2025/02/27: Ceasing to be a substantial holder*
  • 2025/02/27: Half Yearly Report and Accounts*
  • 2025/02/26: Application for quotation of securities - PYC*
  • 2025/02/24: Despatch of Notice to Ineligible Retail Shareholders*
  • 2025/02/24: Despatch of Retail Offer Document*
*refer to company website